<DOC>
	<DOCNO>NCT02606019</DOCNO>
	<brief_summary>The burden dengue infection increase due current non-specific classification . A pilot study conduct evaluate five biomarkers : neopterin , vascular endothelial growth factor ( VEGF ) , thrombomodulin , Vascular Cell Adhesion Molecule 1 ( VCAM-1 ) pentraxin 3 ( PTX-3 ) . VEGF PTX-3 two potential biomarkers differentiate severe dengue non-severe dengue case . The analysis severe dengue non-severe dengue case indicate VEGF able discriminate two category . Though VCAM-1 PTX-3 statistically significant , p-values margin pre-determined p-value less 0.05 . Hence , study aim evaluate VEGF PTX-3 level differentiate severe dengue non-severe dengue case . The secondary objective evaluate correlation VEGF PTX-3 level full blood count ( platelet , white blood cell count haematocrit ) liver function test ( alanine aminotransferase aspartate ) .</brief_summary>
	<brief_title>The Use Biomarkers Predicting Dengue Outcome</brief_title>
	<detailed_description>The burden dengue infection increase due current non-specific classification . A pilot study conduct evaluate five biomarkers : neopterin , vascular endothelial growth factor ( VEGF ) , thrombomodulin , Vascular Cell Adhesion Molecule 1 ( VCAM-1 ) pentraxin 3 ( PTX-3 ) . VEGF PTX-3 two potential biomarkers differentiate severe dengue non-severe dengue case . The analysis severe dengue non-severe dengue case indicate VEGF able discriminate two category . Though VCAM-1 PTX-3 statistically significant , p-values margin pre-determined p-value less 0.05 . Hence , study aim evaluate VEGF PTX-3 level differentiate severe dengue non-severe dengue case . The secondary objective evaluate correlation VEGF PTX-3 level full blood count ( platelet , white blood cell count haematocrit ) liver function test ( alanine aminotransferase aspartate ) . This prospective cohort study patient follow day presentation attend practitioner patient discharge . The blood sample obtain daily follow-up . The demography clinical final diagnosis obtain medical record patient . This study aid triaging dengue case thereby reduce need unnecessary admission well focused management might develop complication dengue infection . This turn reduce workload cost treat dengue infection .</detailed_description>
	<mesh_term>Dengue</mesh_term>
	<criteria>Participants age 15 . Participants must recruit within first three day fever . Positive dengue NS1Ag . Confirmed later pair dengue IgM/IgG . Final diagnosis severe dengue nonsevere dengue . Participants le 15 year old . Pregnant mother . Participants autoimmune disorder , haematological disorder , cancer , cardiovascular disease , long term warfarin aspirin . Participants previously treat dengue infection ( secondary dengue infection exclude dengue IgM/IgG ) .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pentraxin 3</keyword>
	<keyword>Vascular Endothelial Growth Factor</keyword>
	<keyword>dengue</keyword>
</DOC>